nifedipine has been researched along with Eclampsia in 17 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Eclampsia: Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia." | 9.10 | A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. ( Allen, JC; Anthony, J; Belfort, MA; Saade, GR, 2003) |
| "The objective was to compare the fetal and maternal effects between parenteral hydralazine and sublingual nifedipine used like antihypertensive drugs in the management of severe preeclampsia." | 9.07 | [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]. ( Flores Padilla, LM; Walss Rodriguez, RJ, 1993) |
| "The objective of this review was to assess the effects of magnesium sulphate compared with phenytoin when used for the care of women with eclampsia." | 8.86 | Magnesium sulphate versus phenytoin for eclampsia. ( Chou, D; Duley, L; Henderson-Smart, DJ, 2010) |
| "To examine the efficacy of magnesium sulfate (MgSO4) as an anticonvulsant in eclampsia and imminent eclampsia." | 7.69 | Magnesium sulfate as an anticonvulsant in eclampsia. ( Raman, NV; Rao, CA, 1995) |
| " The treatment regimen included use of nifedipine as an antihypertensive, magnesium sulfate as an anticonvulsant, rapid interruption of pregnancy, and admission to the ICU." | 5.16 | Management of eclampsia at Assiut University Hospital, Egypt. ( Abd El Aal, DE; Shahin, AY, 2012) |
| "Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia." | 5.10 | A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. ( Allen, JC; Anthony, J; Belfort, MA; Saade, GR, 2003) |
| "In a prospective controlled trial 91 consecutive women with eclampsia were randomly allocated either to a magnesium sulphate and nifedipine regime or to a lytic cocktail and nifedipine group." | 5.07 | A safer and more effective treatment regimen for eclampsia. ( Bhalla, AK; Dhall, GI; Dhall, K, 1994) |
| "The objective was to compare the fetal and maternal effects between parenteral hydralazine and sublingual nifedipine used like antihypertensive drugs in the management of severe preeclampsia." | 5.07 | [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]. ( Flores Padilla, LM; Walss Rodriguez, RJ, 1993) |
| "The objective of this review was to assess the effects of magnesium sulphate compared with phenytoin when used for the care of women with eclampsia." | 4.86 | Magnesium sulphate versus phenytoin for eclampsia. ( Chou, D; Duley, L; Henderson-Smart, DJ, 2010) |
| "To examine the efficacy of magnesium sulfate (MgSO4) as an anticonvulsant in eclampsia and imminent eclampsia." | 3.69 | Magnesium sulfate as an anticonvulsant in eclampsia. ( Raman, NV; Rao, CA, 1995) |
| "A review of the pathophysiology and treatment of pre-eclampsia indicates that vasospasm and vascular hyperreactivity are important elements in the disease process and its control." | 2.36 | Possible treatment of pre-eclampsia with calcium channel blocking agents. ( Zaret, GM, 1983) |
| "She also had retinal hemorrhages in both eyes and a hemorrhagic infarct in the left occipital lobe that resulted in a permanent right homonymous hemianopia and a persistently depressed acuity of 20/100 OS." | 1.33 | Permanent visual deficits secondary to the HELLP syndrome. ( Ayazifar, M; Murphy, MA, 2005) |
| "Posterior reversible encephalopathy syndrome (PRES) is an acronym that identifies a new clinico-neuroradiologic entity occurring in association with different conditions." | 1.33 | PRES: posterior or potentially reversible encephalopathy syndrome? ( Abbate, M; Ferlazzo, E; Granata, F; Mazzù, I; Musolino, R; Narbone, MC, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arulkumaran, N | 1 |
| Lightstone, L | 1 |
| Vadhera, RB | 1 |
| Simon, M | 1 |
| Karunatilake, H | 1 |
| Vithiya, K | 1 |
| Arasalingam, A | 1 |
| Piyasiri, A | 1 |
| Duley, L | 1 |
| Henderson-Smart, DJ | 1 |
| Chou, D | 1 |
| Abd El Aal, DE | 1 |
| Shahin, AY | 1 |
| Greene, MF | 1 |
| Belfort, MA | 1 |
| Anthony, J | 1 |
| Saade, GR | 1 |
| Allen, JC | 1 |
| Murphy, MA | 1 |
| Ayazifar, M | 1 |
| Sharma, S | 1 |
| Bagga, R | 1 |
| Modi, M | 1 |
| Narbone, MC | 1 |
| Musolino, R | 1 |
| Granata, F | 1 |
| Mazzù, I | 1 |
| Abbate, M | 1 |
| Ferlazzo, E | 1 |
| Zaret, GM | 1 |
| Ram, CV | 2 |
| Korzets, Z | 1 |
| Ben-Chitrit, S | 1 |
| Bernheim, J | 1 |
| Bhalla, AK | 1 |
| Dhall, GI | 1 |
| Dhall, K | 1 |
| Walss Rodriguez, RJ | 1 |
| Flores Padilla, LM | 1 |
| Raman, NV | 1 |
| Rao, CA | 1 |
| Meese, RB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Sildenafil Citrate in Management of Mild Pre-eclampsia: A Randomized Controlled Trial[NCT03262961] | Phase 2/Phase 3 | 80 participants (Anticipated) | Interventional | 2016-09-15 | Recruiting | ||
| Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)[NCT00293735] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2015-06-30 | Withdrawn (stopped due to Lack of funding) | ||
| A Novel Protocol for Postpartum Magnesium Sulfate in Severe Preeclampsia When the Woman Received Less That 8 Hours Before Delivery. Six Versus Twenty-four Hours Postpartum[NCT02317146] | Phase 2/Phase 3 | 280 participants (Actual) | Interventional | 2013-11-30 | Completed | ||
| Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia Receiving Treatment for More Than 8 Hours Before Delivery. A Randomized Multicenter Clinical Trial .[NCT02307201] | Phase 2/Phase 3 | 1,114 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for nifedipine and Eclampsia
| Article | Year |
|---|---|
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Dia | 2013 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hyperten | 2014 |
Magnesium sulphate versus phenytoin for eclampsia.
Topics: Anticonvulsants; Clonazepam; Diazepam; Drug Combinations; Eclampsia; Female; Humans; Magnesium Sulfa | 2010 |
Possible treatment of pre-eclampsia with calcium channel blocking agents.
Topics: Calcium Channel Blockers; Eclampsia; Female; Fetus; Humans; Hypertension; Nifedipine; Placenta; Pre- | 1983 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1984 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1985 |
4 trials available for nifedipine and Eclampsia
| Article | Year |
|---|---|
Management of eclampsia at Assiut University Hospital, Egypt.
Topics: Adolescent; Adult; Anticonvulsants; Antihypertensive Agents; Clinical Protocols; Combined Modality T | 2012 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A safer and more effective treatment regimen for eclampsia.
Topics: Adult; Drug Synergism; Drug Therapy, Combination; Eclampsia; Female; Humans; Magnesium Sulfate; Nife | 1994 |
[Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents].
Topics: Administration, Sublingual; Antihypertensive Agents; Apgar Score; Drug Evaluation; Eclampsia; Female | 1993 |
7 other studies available for nifedipine and Eclampsia
| Article | Year |
|---|---|
Hypertension and generalised tonic-clonic seizures occurring 41 days after elective caesarian section.
Topics: Adult; Cesarean Section; Eclampsia; Elective Surgical Procedures; Epilepsy, Generalized; Epilepsy, T | 2008 |
Magnesium sulfate for preeclampsia.
Topics: Anticonvulsants; Eclampsia; Female; History, 17th Century; History, 18th Century; History, 20th Cent | 2003 |
Permanent visual deficits secondary to the HELLP syndrome.
Topics: Adult; Blood Pressure; Brain Infarction; Drug Therapy, Combination; Eclampsia; Female; Furosemide; H | 2005 |
Paraparesis with complete recovery in antepartum eclampsia.
Topics: Adult; Antihypertensive Agents; Brain Diseases; Delivery, Obstetric; Eclampsia; Female; Follow-Up St | 2006 |
PRES: posterior or potentially reversible encephalopathy syndrome?
Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Antihypertensive Agents; Brain; Brain Diseases; Cl | 2006 |
Bradycardia as a presenting feature of late postpartum eclampsia.
Topics: Adult; Bradycardia; Drug Therapy, Combination; Eclampsia; Female; Humans; Magnesium Sulfate; Nifedip | 1994 |
Magnesium sulfate as an anticonvulsant in eclampsia.
Topics: Adolescent; Adult; Anticonvulsants; Birth Weight; Delivery, Obstetric; Eclampsia; Female; Humans; Ma | 1995 |